Gender Differences in Clinical Psychopharmacology
J Clin Psychiatry 2005;66(9):1191
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Biological differences between men and
women appear, at least in part, to be related to
variation in levels and changes in sex steroids
that subsequently interact with neurotransmitters.
Reproductive-aged women have repetitive
variations in sex hormones with each
monthly cycle that influence the onset, chronicity,
and outcome of a variety of psychiatric
illnesses. Variations in brain structure and function
and in pharmacokinetics may also contribute
to psychiatric outcomes.